These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2990703

  • 1. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH, Pahwa SG, Popovic M, Sarngadharan MG, Gallo RC.
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [Abstract] [Full Text] [Related]

  • 2. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 May 23; 35(20):334-9. PubMed ID: 3010072
    [Abstract] [Full Text] [Related]

  • 3. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
    Gill PS, Levine AM, Meyer PR, Aguilar SL, Rarick M, Parker JW, Rasheed S.
    Arch Intern Med; 1986 Aug 23; 146(8):1501-4. PubMed ID: 3015064
    [Abstract] [Full Text] [Related]

  • 4. Pediatric AIDS: a disease spectrum causally associated with HTLV-III infection.
    Parks WP, Scott GB.
    Cancer Res; 1985 Sep 23; 45(9 Suppl):4659s-4661s. PubMed ID: 2990704
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ, Antonen J, Valle SL, Kazakevicius R, Saxinger C, Gallo RC, Ranki A.
    Cancer Res; 1985 Sep 23; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [Abstract] [Full Text] [Related]

  • 6. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
    Ann Intern Med; 1986 Aug 23; 105(2):234-7. PubMed ID: 3014942
    [Abstract] [Full Text] [Related]

  • 7. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE.
    Salud Publica Mex; 1986 Aug 23; 28(2):180-5. PubMed ID: 3014666
    [No Abstract] [Full Text] [Related]

  • 8. The Walter Reed staging classification for HTLV-III/LAV infection.
    Redfield RR, Wright DC, Tramont EC.
    N Engl J Med; 1986 Jan 09; 314(2):131-2. PubMed ID: 2934633
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical spectrum of HTLV-III in humans.
    Groopman JE.
    Cancer Res; 1985 Sep 09; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701
    [Abstract] [Full Text] [Related]

  • 11. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH, Saltzman BR, Rogers MF, Kahl PA, Lesser ML, Mayers MM, Klein RS.
    N Engl J Med; 1986 Feb 06; 314(6):344-9. PubMed ID: 3456076
    [Abstract] [Full Text] [Related]

  • 12. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P, Weaver M, Wiggs B, O'Shaughnessy M.
    Can Med Assoc J; 1985 Aug 15; 133(4):286-92. PubMed ID: 2990652
    [Abstract] [Full Text] [Related]

  • 13. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Mar 14; 35(10):152-5. PubMed ID: 3005822
    [Abstract] [Full Text] [Related]

  • 14. HTLV and immunosuppression.
    Essex M, Kanki P, Allan J, Barin F, McLane MF, Lee TH, Kitchen L, Homma T, Malone G, Yokota T.
    Princess Takamatsu Symp; 1984 Mar 14; 15():309-18. PubMed ID: 6100649
    [Abstract] [Full Text] [Related]

  • 15. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG, DeVico AL, Bruch L, Schüpbach J, Gallo RC.
    Princess Takamatsu Symp; 1984 Mar 14; 15():301-8. PubMed ID: 6100648
    [Abstract] [Full Text] [Related]

  • 16. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C, Levine PH, Dean A, Lange-Wantzin G, Gallo R.
    Cancer Res; 1985 Sep 14; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [Abstract] [Full Text] [Related]

  • 17. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ, Schechter MT, Jeffries E, Douglas B, Maynard M, O'Shaughnessy M.
    Can Med Assoc J; 1985 Jul 01; 133(1):28-32. PubMed ID: 2988730
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R, Redfield RR, Broder S.
    J Clin Invest; 1986 Aug 01; 78(2):439-47. PubMed ID: 3016028
    [Abstract] [Full Text] [Related]

  • 19. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS.
    Biberfeld P, Porwit-Ksiazek A, Böttiger B, Morfeldt-Månsson L, Biberfeld G.
    Cancer Res; 1985 Sep 01; 45(9 Suppl):4665s-4670s. PubMed ID: 2410110
    [Abstract] [Full Text] [Related]

  • 20. AIDS in Haitian-Americans: a reassessment.
    Frank E, Weiss SH, Compas JC, Bienstock J, Weber J, Bodner A, Landesman SH.
    Cancer Res; 1985 Sep 01; 45(9 Suppl):4619s-4620s. PubMed ID: 2990695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.